Vendor managed inventory (VMI) services for USG procured 165,906 doses of neulasta product to mitigate injuries caused by exposure to chemical, biological threat agents, physical, radiologic and…
Ended Definitive Contract Awarded Last action
- Contract number
- 75A50124C00011
- Awardee
-
Amgen USA Inc. UEI XPGNQMXHP493
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $811,924
Award facts
- Opportunity
-
- 75A50124R00002 Solicitation number
- Contract value 100% obligated
- $811,924.33 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Thousand Oaks, CA 91320, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$42,095 | |
| Exercise an Option | $273,613 | |
| Original award | $580,407 |
About this award
This is a definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Amgen USA Inc. The contract is for $811,924.33 and involves the provision of Vendor Managed Inventory (VMI) services for 165,906 doses of the drug Neulasta, which is used to mitigate injuries caused by exposure to chemical, biological, radiological, nuclear, and physical threats. The contract does not have a set-aside designation and is a firm fixed-price arrangement with a completion date of December 16, 2024.
Amgen USA Inc. is a subsidiary of the biotechnology company Amgen Inc. and is a registered federal contractor that has secured several significant contracts with HHS and other agencies, including a Federal Supply Schedule contract with the Department of Veterans Affairs and an indefinite delivery contract focused on supplying calcitonin gene-related peptide agents. These contract vehicles demonstrate Amgen USA's role in providing critical medical products and services to support federal healthcare initiatives.
Description
Vendor managed inventory (VMI) services for USG procured 165,906 doses of neulasta product to mitigate injuries caused by exposure to chemical, biological threat agents, physical, radiologic and nuclear exposures.
Quick answers
Who was awarded contract 75A50124C00011?
75A50124C00011 was awarded to Amgen USA Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on March 12, 2024.
How much is contract 75A50124C00011 worth?
The government has obligated $811,924 on 75A50124C00011.
Was contract 75A50124C00011 competed?
The extent of competition for 75A50124C00011 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award